A genetic polymorphism in a functional domain of human pregnancy zone protein: the bait region Genomic structure of the bait domains of human pregnancy zone protein and α2 macroglobulin by Marynen, P. et al.
Volume 262, number 2, 349-352 FEBS 08287 March 1990 
A genetic polymorphism in a functional domain of human pregnancy 
zone protein: the bait region 
Genomic structure of the bait domains of human pregnancy zone protein and % 
macroglobulin 
P. Marynen, K. Devriendt, H. Van den Berghe and J.J. Cassiman 
Center for Human Genetics, University of Leuven, Campus Gasthuisberg, Herestraat 49, B-3000, Leuven, Belgium 
Received 24 January 1990 
Genomic clones containing the exons coding for the bait domain of human pregnancy zone protein and cr, macroglobnlin were isolated and frag- 
ments containing the bait exons were sequenced. It is shown that the bait domains of both Q macroglobnlin and pregnancy zone protein are encoded 
by two exons, with conserved exon/intron boundaries. A genetic polymorphism showing either a Met or a Val residue as the sixth amino acid 
of the pregnancy zone protein bait domain was detected with the rare Met allele showing a gene frequency of 0.065. 
Proteinase inhibitor; Macroglobulin, a- 
1. INTRODUCTION 
The cy macroglobulin proteinase inhibitor family is 
represented in humans by cu2 macroglobulin (LY~M) and 
pregnancy zone protein (PZP). Unlike cuzM which is 
constitutively present at high levels in plasma, PZP 
levels, normally very low in both males and females 
(approx. 10 bg/ml), rise dramatically during pregnancy 
to reach 2 mg/ml at term [l]. Proteinase cleavage of a 
specific ‘bait’ domain of LY macroglobulins, located 
near the middle of the polypeptide chains of the 
macroglobulin subunits, leads to a sequence of events 
resulting eventually in the physical entrapment of the 
proteinase, which is then no longer able to reach high 
molecular weight substrates uch as proteins [2]. The 
resulting CY macroglobulin-proteinase complexes are ef- 
ficiently cleared from the circulation by receptor- 
mediated endocytosis [3]. The spectrum of proteinases 
inhibited by each particular a macroglobulin is 
therefore defined by the amino acid (aa) sequence of its 
bait domain, which must reflect the specificity of the 
inhibited proteinases. cy Macroglobulins are highly con- 
served proteins, except for the bait domains which vary 
widely in length and aa sequence [4], and different cx 
macroglobulins thus inhibit different (complementary) 
sets of proteinases. The suggestion was made that the 
occurrence of varying bait domains might be the result 
of exon shuffling and positive Darwinian selection [4]. 
The aa sequence of a cyanogen bromide fragment 
spanning the PZP bait domain and the sites of cleavage 
by several proteinases within the bait was published 
recently [4]. The isolation of the two exons coding for 
the PZP bait domain is reported here. Sequencing of 
this clone revealed a rare Val-Met polymorphism in 
this important functional domain of PZP. An assay 
system, relying on allele-specific oligonucleotides was 
developed allowing for the rapid detection of both PZP 
bait domain alleles. To evaluate the possible genetic 
origin of the diversity of different bait domains, the ex- 
on structure of the human CYZ macroglobulin bait do- 
main was determined and compared to the genomic 
structure of the PZP bait. 
2. MATERIALS AND METHODS 
Correspondence address: P. Marynen, Center for Human Genetics, 
University of Leuven, Campus Gasthuisberg, Herestraat 49, B-3000 
Leuven, Belgium 
The nucleotide sequence(s) presented here has (have) been submitted 
to the EMBL/GenBank database under the accession number 
no.YO753S 
The PZP clone was isolated from a human placental DNA genomic 
library, cloned into the cosmid vector pWElS and obtained from 
Stratagen (La Jolla, CA, USA). The o2M clone was isolated using an 
(YAM cDNA probe [S] from a human genomic library cloned into 
Charon 4a (courtesy of Dr J. Darby, Stanford University, CA, USA). 
The screening, clone purification, restriction mapping and subclon- 
ing into pGEM.3Z (Promega, Madison, USA) were done according 
to established procedures. Sequencing was performed with T7 DNA 
polymerase (Pharmacia, Uppsala) with supercoiled plasmid as a 
template. Random shotgun cloning was used to obtain the sequence 
of both strands of the inserts. 
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Fig.1. Schematic representation of the genomic PZP and LVZM clones. The newly isolated PZP clone (C4-1) is shown in relation to the previously 
described [5] PZP clone EPZP6. The fragment containing the two PZP bait exons is shown enlarged (PZP BAIT). E, EcoR; H, Hind; B, BgnI; 
K, KpnI site. The exons are illustrated as boxes, which are shaded for residues conserved between PZP and crzM and open for bait domain 
residues. The crosshatched lines delimit the sequences shown in fig.2. Bottom, the structure of the cuzM clone containing the two bait exons is 
shown. 
The forward primer (5 ’ TAC TGT CAA GTG TTT CGC CA) and 
reverse primer (5’ AGC TAT CAC CAG CTA ACT CA) for the 
polymerase chain reactions (PCR) were synthesized on a Cyclone 
(Biosearch, San Raphael, CA) DNA synthesizer and used without 
further purification. PCR was performed with 1 fig human genomic 
DNA in 50 mM KCl, 10 mM Tris-HCI, pH 8.3, 1.5 mM MgClz, 
0.01% gelatine, 100 pmol primers, 200 PM dNTPs and 2.5 units of 
Taq DNA polymerase (Perkin-Elmer Cetus, Norwalk, CA). Twenty- 
five amplification cycles (1 min at 94”C, 2 min at 6O”C, 1 min at 
72°C) were performed on a PCR thermal cycler (Perkin Elmer- 
Cetus); each experiment included negative controls. Two allele- 
specific oligonucleotides, AS0 PZP BAIT-Val (5’ CCC TTC CGT 
PZP-ftactgtcaagtgtttcgcca taaaattaatataaggatactggaattacatagagaagtctctaaggataatatgttttatatattctaa 90 
PZP-tcaagcttacaagtagattgaacaattatttttttcca(lGGGATGGGATTGT~T~T~TCCG~C~TCG 160 
PZP - GMGLKVFTNSKIRKPKS 
I I I I I I I I I I I I I I 
A2t4- 649-DMGL KA FTNS K IRKP KM 
A2U-ttttgtttgcagGACATGGGCTTAAAGGCATTCACCAACTCAAAGATTCGTAAACCCAAAATG 
PZP-TGTTCAGTCA~~~~GT~TC~AT~TAT~gtaaaacagcaatttgcttttaattttatttcatg 
PZP-C SerValIleProSe~~SarAlaGlyAlaValGlyGLA/ 
I 
A2M-C ProGLnLeuGLnOLn~rGl~atEiaGlyProGluGlyLe~gValGly~e~rG/-666 
A2H_TGTCCACAGCTTCAACAGTATGAMTGCATGGACCTGtaaacaaaaa------------------ 
PZP-tccaacaatattactatgcccaaaatgctaaaatgaggtaatgtagccctatttccactttatacacacaa~aaaccaagattcaaatt 
PZP-aattgtttcttgctgagg tgacttagctggtgatagctl- ____-_____2493 nt________________________________ 
PZP-cttactttagCM;GTCT~~TffiT~~~~CATATGTTCCTCMTT~~ATATMTGTGAT~CTT~TMTG~~GT 
PZP - laGlyLeuGlyValValGluArgProTyrValProGlnLeuGlyThrTyrAsnVa1IleProLeuAsnAsnGluGlnSer 
A2M - 666-luSerAspVal.MetGlyAr&GlyaisAlaArgLauValHisVal 
A2M-----------------------1610 nt-------ctcaccatagAGTCAGATGTAATGGGAAGAGGCCATGCACGCCTGGTGCATGTT 
PZP-TCAGGGCCMjTCCCTGAMCGGTGCGMGCTATTTTCCTG~ACTT~ATCT~AGTT~T~AGTG~taagtaact 
PZP-SerGlyProValProE T V R S Y F P E T W I W E L V A V N/ 
I I I I IIIIIIIIIII II 
A2M-GluGluProIiisTbrE T V R K Y F P E T W I W D L V V V N/-724 
A2M-GAAGAGCCTCACACGCGTACGAAAGTACTTCCCTGAGACAT~ATCT~ATTT~~T~T~taagtaact 
270 
360 
2951 
3032 
Fig.2. Sequence of PZP and cvzM bait exons. DNA sequences of both bait exons of PZP Met allele and cu2M are shown. Intron sequences are 
shown in lower case, exon sequences in upper case. The conserved protein sequences are given in single letter amino acid code, the bait domain 
sequences are given in three letter code. The numbering of WM amino acids is as in 141. The sequences of the PCR primers are shown by arrows, 
the sequence of the AS0 is boxed, the polymorphic Met residue is underlined. The PZP gene fragment was fully sequenced. The full sequence 
is submitted to Genbank (CA), access number YO7535. The intronic distance between the two cvzM bait domain exons was determined with 
restriction mapping. 
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Fig.3. Mendelian inheritance of the PZP bait domain polymorphism. PCR products obtained from DNA of the different family members was 
denatured and dot spotted onto nylon membranes. The membranes were then hybridized to “P-labeled ASOs specific for the Met allele (upper 
row) or the Val allele (lower row). The controls are A: no genomic DNA added to the PCR reaction; B: 100 ng of a plasmid carrying the Val 
allele and C: 100 ng of a plasmid carrying the Met allele. 
OTC TGC A) and AS0 PZP BAIT-Met (5 ’ CCC TTC CAT GTC 
TGC A) were labeled with the polymxleotide kinase and hybridized 
(2000000 dpm/ml) to dot blots in 5 x SSPE, 0.2% SDS, 200 FgJml 
heparin at 37°C. Allele-specific hybridization was observed on 
autora~ography after a final wash in 2 x SSPE, 0.2% SDS for 5 min 
at 50°C for AS0 PZP BAIT-Met and JS’G for AS0 PZP BAIT-Val. 
3. RESULTS 
We previously reported the characterization of a 
genomic PZP clone (EPZP6) spanning the 3 ’ end of 
the PZP gene [a]. With a probe derived from the 5 ’ end 
of EPZP6, a cosmid clone C4-1 was isolated reaching 
21.5 kb upstream of EPZP6 (fig.1). Sequencing of a 
3.7 kb fragment of C4-1, and comparison with the 
published partial aa sequence of PZP 171, revealed the 
presence of 2 exons coding for 35 and 51 aa, respective- 
ly (figs 1 and 2). Inspection of this sequence shows that 
the PZP bait domain, as defined by Sottrup-Jensen et 
al. [4], spans from aa 17 of the first exon to aa 33 of 
the second exon. Interestingly, the DNA sequence 
predicts a Met residue at position 6 of the PZP bait do- 
main instead of a Val as published. In view of the possi- 
ble significance of a mutation in this functional domain 
of PZP, this observation was further investigated. 
First, primers were designed to amplify the first exon of 
the PZP bait (fig.2) with the PCR. The bait exon 1 of 
the DNA of 8 unrelated individuals was amplified, 
cloned into &r&-cut pGEM3Z and 10 independent 
clones for each individual were sequenced. Seven in- 
dividuals showed only GTG (Val) as the 21th codon of 
bait exon 1. The 8th individual showed a GTG (Val) 
codon in 4 clones and an ATG (Met) codon in 6 clones, 
suggesting heterozygosity at this locus. To exclude PCR 
or cloning artifacts, the PCR, cloning and sequencing 
were repeated for individual 8 on another DNA sample, 
with identical results. Second, two allele-specific 
oligonucleotides (AS0 PZP BAIT-Val and AS0 PZP 
BAIT-Met) were designed and the hybridization and 
wash conditions for the specific detection of the Met 
and the Val allele were determined (section 2). The 
DNA samples of 32 unrelated individuals, parents of 
small nuclear families, were amplified and assayed. 28 
samples were homozygous for the GTG codon while 4 
heterozygotes, belonging to 3 families, showed both 
GTG and ATG alleles. Mendelian inheritance of the 
Met/Val polymorphism in two representative families 
is shown in fig.3. 
Exon shuffling was suggested as a possible 
mechanism by which different bait domains could have 
arisen [4]. As shown here, the PZP bait domain is en- 
coded by two exons separated by a type I intron. In 
view of the possible implications as to the mechanism 
of divergence of the bait domains, the corresponding 
region of the CQM gene was cloned, exons coding for 
the @zM bait were identified and the intron/exon boun- 
daries determined by sequencing (fig.2). Comparison 
of these data with the GQM cDNA sequence [S] shows 
an identical genomic organization with two exons (37 
aa and 39 aa, respectively) coding for the a2M bait do- 
main, separated by a type I intron (figs 1 and 2). 
4. DISCUSSION 
The data presented here demonstrate a polymor- 
phism in the bait domain of PZP, the sixth amino acid 
of this domain being either a Val or a Met. Assuming 
a Hardy-Weinberg equilibrium, the frequency of the 
Met allele can be estimated to be 0.065, with 0.4% of 
the individuals being homozygotes. This could explain 
why the polymorphism was not detected by protein se- 
quencing. Furthermore, the presence of a new Met 
residue would generate fragments of different length 
upon cyanogen bromide cleavage, separating the Val 
bait peptides from the Met bait fragments upon further 
purification and sequencing. 
The cr macroglobulins represent an interesting case of 
molecular evolution containing a bait domain defining 
their specificity as proteinase inhibitors, differing in 
length and aa sequence in an otherwise well-conserved 
polypeptide [2]. Bait domains of LY macroglobulins 
were shown to be exposed at the surface of the molecule 
[8,9], but comparison of bait domains of different a* 
macroglobulins failed to detect common structural 
motives in this domain [4]. It is therefore conceivable 
that a mutation in the bait domain would not affect the 
molecular mechanism by which Q! macroglobulins en- 
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trap proteinases, although it would of course affect the 
specificity of the inhibitor. This, and positive Darwi- 
nian evolution as suggested by L. Sot&up-Jensen et al. 
[4], could then account for Ihe rapid evolution of the 
bait domain of different cx macroglobulins. Exon shuf- 
fling has also been mentioned as a mechanism by which 
different baits might have evolved [4]_ The present data 
seem not to support this view. Indeed, both the CQM 
and the PZP bait domains are encoded by two exons 
with boundaries which do not coincide with the boun- 
daries of the respective xons, while the 5 ’ end of the 
first exon and the 3’ end of the second occur at con- 
served aa residues in both genes, The intronlexon 
boundaries at the rat LYZM bait domain are also iden- 
tical to the one reported here for human PZP and CQM, 
showing cross-species conservation of this genomic 
organization [lo]. The PZP and the human CY~M bait 
exon, and the rat tvzM bait exons are all interrupted by 
a type f intron which would argue against, although not 
exclude, intron sliding [ll] as a mechanism by which 
the lengths of different bait domains could vary. 
The physiology of PZP is not yet well understood 
and the polymorphism of the bait domain described 
here does not occur at the primary site of cleavage by 
the proteinases reported recently [4]. This set of pro- 
teinases, however, might be different from the pro- 
teinases against which PZP protects the organism. 
While low PZP levels were reported to be carrelated 
with spontaneous abortion eariy in pregnancy f 121% no 
correlation was found between PZP levels and severe 
pre-eclampsia 1131. As shown here, overall PZP levels, 
however, do not necessarily represent he proteinase in- 
hibitory potential of PZP, which could be influenced 
by polymorphisms like the bait domain polymorphism 
reported here. The probes for rapid detection of this 
polymorphism, devdoped here, wifl aBow us to in- 
vestigate proteinase inhibition by the different PZP 
allotypes and their possible reIation to PZP physiology 
in the future. 
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